A. Forastiere

Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

Carole Fakhry, William H. Westra, S. Li et al. · JNCI Journal of the National Cancer Institute · 2008 · 2.8K citations · Full text

NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network.

A. Forastiere, H Goepfert, Don R. Goffinet et al. · PubMed · 1998 · 33 citations

Neck Cancer, Medicine, Cancer Management +11

A phase II trial of PS-341 (bortezomib) followed by the addition of doxorubicin at progression in incurable adenoid cystic carcinoma of the head and neck: An Eastern Cooperative Oncology Group study

Athanassios Argiris, Meredith A. Goldwasser, Barbara Burtness et al. · Journal of Clinical Oncology · 2006 · 19 citations

Pathology, Pharmacotherapy, Tumor Biology +16

A Phase II study of axitinib (AG-013736), a potent inhibitor of VEGFRs, in patients with advanced thyroid cancer

S. Kim, Lee S. Rosen, Ezra E.W. Cohen et al. · Journal of Clinical Oncology · 2006 · 17 citations

Potent Inhibitor, Advanced Thyroid Cancer, Pathology +16

Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/intergroup phase III trial

Jay S. Cooper, Thomas F. Pajak, A. Forastiere et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 12 citations

Advanced Head, Surgical Oncology, Oncology +10